If you are launching your first product and need to
be on the shelf within about three months on a modest budget, a stock formula is
almost always the right choice — you are branding a proven recipe, so the
cost and timeline are low and there is no formulation work to fund. Choose custom
development when differentiation matters, you can invest six to nine months and
the budget to match, and you intend to own what you build. Most brands start with
a stock formula to prove demand, then move to custom on their second or third
product once the sales justify the investment. The dividing line is not which is
“better” — it is your stage, your budget, and how distinctive the product
actually needs to be.
You have read what white label, private label and contract manufacturing mean.
Now you are staring at a real decision: take a formula the factory already has,
or pay to develop your own from scratch. That single choice sets your upfront
cost, your time to market, how much a competitor can copy you, and — the
part most founders miss until it is too late — who owns the formula if you
ever want to move factories. This guide gives you the decision rule, explains the
testing “cliff” that quietly turns a cheap tweak into an expensive custom project,
and says plainly where a full contract manufacturer like Moe’s Group is the wrong
place to start.
What is a stock formula, and who owns it?
A stock formula is a pre-made, pre-tested product the manufacturer already
owns. You add your branding; you do not own the recipe, and other brands can sell
a product made from the identical formula. This is white label
territory in the model this site uses throughout — the cheapest and fastest
route, because all the development and safety work is already done and amortised
across everyone who buys it. Add light customisation exclusive to your brand
— a different fragrance, a colour change, a small addition within the
formula’s validated stability window — and you move into
private label: a little more cost, a little more lead time,
still the manufacturer’s underlying recipe.
The ownership point is the one to internalise now, because it does not change
however much you tweak the surface: with a stock or private-label formula, the
manufacturer keeps the formula unless a contract explicitly says
otherwise. That is not a trap — it is the deal, and it is why the route is
cheap. But it means you cannot pick up “your” product and take it to a different
factory, because the recipe was never yours. We cover this in depth in
who
owns the formula in private label skincare; the short version is: get the
ownership terms in writing before you commit, whichever route you take.
What does custom formulation actually involve?
Custom formulation — contract manufacturing in the
three-tier model — is a formula built to your own specification rather than
taken off a shelf. It is the most expensive and slowest of the three routes,
because you are paying for real R&D: a development brief, ingredient
selection, bench prototyping, iteration on texture and sensory feel, and a full
programme of stability and safety testing before anything can be filled at scale.
In exchange you get a product no competitor can buy, and — if you contract
for it — the possibility of owning the formula itself.
What that looks like at a real US manufacturer is instructive if you are
weighing the route. Moe’s Group, the contract manufacturer that supports this
publication, lays out its
custom formulation and
R&D process step by step — discovery consultation, ingredient
selection, collaborative development, the first sample test, sensory design. Read
it not as an advert but as a checklist of the stages a genuine custom project
runs through, so you can tell whether a quote you have been handed actually
includes them or is quietly a stock formula wearing a custom price tag. One word
to keep exact while you are in these conversations: a cosmetics facility is
FDA registered, which is a filing status. It is never “FDA
approved” — the FDA does not approve cosmetic products or the facilities
that make them, and a manufacturer who says otherwise has told you something
false.
The stability testing cliff: when a tweak becomes a custom project
Here is the mechanism that explains the whole cost ladder, and it is the part
founders discover the expensive way. A stock formula comes with its safety and
stability data already done. Change the fragrance or the colour within the
window the manufacturer has validated, and that data still holds. But modify the
base — the emulsion, the preservative system, the active
concentrations — and you invalidate the existing testing. The project now
needs new accelerated stability testing (8–12 weeks is typical), fresh
preservative-efficacy testing, and possibly a new safety assessment. You have,
without meaning to, tipped a cheap private-label tweak over the edge into a
custom project with custom timelines and custom cost.
This is why the white label < private label < contract manufacturing
ordering is not arbitrary pricing — it is the testing and development work
that drives each step. It also carries a regulatory warning. Pushing a formula
toward higher active concentrations to make it feel more “clinical” does not buy
you the right to make stronger claims; the opposite. The FDA is explicit that
intended use and certain claims are what separate a cosmetic from a drug —
see
Is It a Cosmetic, a Drug, or Both? A custom formula lets you
build something distinctive; it does not let you say it treats, cures or prevents
anything. Keep the claim inside cosmetic structure/function language whatever the
concentration.
- White label (stock formula, unbranded)
- A generic stock product sold to many retailers, with no formula
modification and no exclusivity — your branding on an identical
product competitors can also sell. The cheapest and fastest
route. The manufacturer owns the formula. - Private label (stock formula, lightly customised)
- A stock formula made exclusive to one brand with some customisation —
fragrance, colour, minor tweaks within the validated stability window.
Costs more and takes longer than white label; sits in the
middle. The base formula and its testing still belong to
the manufacturer. - Contract manufacturing (custom formulation)
- A formula developed to the brand’s own specification, with
ownership negotiable and set in the contract. The
most expensive and slowest route because the R&D and
the full testing programme are done from scratch. This is what “custom
development” means.
The one-line map: white label < private label < contract
manufacturing, ascending on cost, on lead time and on how much control
you have over the formula. “Stock formula” lives on the left of that line;
“custom formulation” lives on the right; a base-formula tweak is the trapdoor
between them. The client’s own
three-tier definitions are the source of truth for that
ordering, and our companion piece
white
label vs private label vs contract manufacturing walks the same ground if you
want the definitions first.
Who should start with stock? Who should go straight to custom?
The decision is less about ambition and more about which of these describes you
right now:
- Testing an idea, budget under roughly $10k, speed over
distinctiveness: start with a stock formula
(white or low-MOQ private label). You can be in market in weeks, the
ownership question is moot because there is nothing bespoke to own, and you
find out whether anyone wants the product before you spend real money on
R&D. The trade-off you are accepting is that a competitor can sell the
identical formula. - Building a real brand, want it to look and feel proprietary, not yet
ready to fund formulation: private label with
customisation. Exclusivity plus surface differentiation, without
the cost of a ground-up recipe — as long as you stay inside the
stability window and do not trip the testing cliff. - Scaling, differentiation is the whole point, you intend to own the
formula: go custom / contract manufacturing. Fund
the development, and negotiate ownership explicitly — “negotiable”
means you must put the transfer in the contract, not assume it. This is the
only route where owning the recipe is even on the table.
The pattern that holds for most brands, and that experienced formulators
recommend, is to start with stock and graduate to custom. An independent
body-care manufacturer, Laeyolabs, lays out the same logic in its comparison of
the stock-formula and custom-development routes (checked 12
September 2026): stock and private-label options while finances are tight, then
custom development as the brand scales into its later product waves. You are not
choosing a route for the life of the company — you are choosing the right
route for the product in front of you this quarter. Timelines differ by route; our guide to
how
long private label skincare takes and the one on
what
private label skincare costs put real ranges on each step.
Where contract manufacturers fit — and where they don’t
A full-service contract manufacturer like Moe’s Group is built for the custom
end of this decision: a brand that wants a skincare, hair-care or body-care
formula developed to its own brief, filled and labelled in one FDA-registered US
facility, and intends to scale it. That is the right fit. Being honest about the
wrong fit is what makes a comparison worth reading, so here it is plainly. The
models and minimum order quantities below change; each entry describes a
manufacturing positioning to confirm at the source on the day you brief
it, not a stated figure.
| If you are… | Better-fit alternatives | Why a full contract manufacturer is the wrong lane |
|---|---|---|
| Testing demand on a small budget, need a low-MOQ stock product | Blanka and similar catalogue private-label providers (checked 12 September 2026) | Custom formulation carries real R&D cost. At the test-demand stage a stock formula is the right move; a development-led manufacturer is not structured for a tiny test run with no R&D investment. |
| Already holding your own formula file (from an independent cosmetic chemist) | Toll / build-to-print manufacturers such as Cosmetic Solutions and other ISO 22716 toll houses (checked 12 September 2026) | If you need production only, not development, you may not need a development-led manufacturer’s R&D capability — and a simpler toll manufacturer may be cheaper. Moe’s Group’s public pages describe custom development from brief; whether it also takes external formulas for production only is not something we could confirm, so ask directly. |
| A formula house separate from manufacturing (maximum IP independence) | Cosmeta and other independent formulators who develop the recipe you then take to production (checked 12 September 2026) | An independent formulator develops the formula and hands it to you; you then choose any factory to make it. That separation is not what a one-roof contract manufacturer offers. |
| Color cosmetics (lipstick, mascara, pressed powder) | Colour specialists such as Twincraft (for bar formats) and dedicated makeup manufacturers (checked 12 September 2026) | Colour and solid formats need different equipment; Moe’s Group is a skincare / hair / body specialist, not a makeup or bar-soap house. |
| A US stock-formula catalogue at scale | Federal Package and other established US stock-formula manufacturers (checked 12 September 2026) | If a proven catalogue product at volume is all you need, a stock-formula-first manufacturer is a more direct fit than a bespoke development shop. |
| OTC drug-cosmetics (SPF sunscreen, anti-acne actives) | Contract manufacturers holding OTC drug manufacturing authorization | OTC drug products are regulated under a separate framework and require a different class of facility from a cosmetics manufacturer. |
None of the entries above states a manufacturer’s MOQ, price or ownership terms
as fact — those are questions for each supplier, and they change. Under
MoCRA, whichever route you choose, the brand that markets the
product is the “responsible person” and carries its own facility-registration,
product-listing and safety-record duties — a factory registering itself does
not discharge them. For neutral reference, the
Personal Care
Products Council is the US trade body, and any ISO 22716 certificate a factory
cites can be checked at
IAF CertSearch.
Frequently asked questions
Does using a stock formula mean other brands sell the same product?
With a pure white-label stock formula, yes — the manufacturer can sell the
identical formula to other brands, and you are competing on branding, price and
distribution rather than the product itself. Private label narrows this: the
formula is made exclusive to you, though it is still the manufacturer’s underlying
recipe. Only custom formulation gives you a product no one else can buy.
Can I own a stock formula if I pay for it?
Not by default. A stock or private-label formula belongs to the manufacturer,
and that is precisely why the route is cheap. Ownership becomes negotiable only
with custom / contract manufacturing, and even then it must be written into the
contract — “negotiable” is not the same as “yours”. Get the ownership terms
in writing before you commit, whichever route you take.
How long does custom formulation take with a US contract manufacturer?
Plan in quarters, not weeks. Custom development runs through briefing,
prototyping and iteration, then a full testing programme — accelerated
stability testing alone is typically 8–12 weeks — before scale-up
filling. Six to nine months from brief to shelf is a realistic planning range,
against roughly weeks-to-a-couple-of-months for a stock or lightly customised
private-label product. Confirm exact timelines with the manufacturer for your
specific formula.
What is the minimum investment for custom cosmetic development?
It varies by manufacturer, category and complexity, and we do not publish a
specific figure for any factory — ask each one directly. What is
consistent is the shape: custom development costs materially more upfront than a
stock formula because you are funding R&D and a full testing programme rather
than buying into work already done. If your budget is at the test-demand stage,
that difference is usually the reason to start with stock.
Is a “private label” formula the same as a “custom” formula?
No, and conflating them is a common and costly mistake. Private label uses a
stock formula the manufacturer owns, even with minor tweaks. Custom formulation
builds a new formula to your brief, with ownership negotiable. They sit at
different ends of the cost, lead-time and control ordering, and the moment you
modify a private-label formula’s base you have effectively started a custom
project — new testing, new cost, new timeline.
Weighing a custom formula you intend to own rather than a stock
product to test with? Ask a contract manufacturer directly how it handles
development, testing, MOQ and formula ownership in writing — Moe’s Group
takes enquiries through its
product inquiry form.
Disclosure: Contract Beauty is published with the
support of Moe’s Group, a contract manufacturer named in this article. We name
competing suppliers and say where Moe’s Group is the wrong choice because a
comparison that always concludes the same way is worth nothing. Manufacturing
models and minimum order quantities change; confirm current terms with any
supplier before you commit. See our
editorial policy.